En studie av Guselkumab versus Risankizumab hos deltakere med moderat til alvorlig aktiv Crohns sykdom (CHARGE)
En fase 3b, multicenter, randomisert, åpen, aktivkontrollert studie for å sammenligne effekt og sikkerhet av Guselkumab versus Risankizumab i behandlingen av deltakere med moderat til alvorlig aktiv Crohns sykdom
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Fase 3
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Study Contact
- Telefonnummer: 844-434-4210
- E-post: Participate-In-This-Study1@its.jnj.com
Studiesteder
-
-
-
Brussels, Belgia, 1200
- Rekruttering
- Cliniques Universitaires Saint Luc
-
Brussels, Belgia, 1070
- Rekruttering
- ULB Erasme Ziekenhuis
-
Genk, Belgia, 3600
- Rekruttering
- Ziekenhuis Oost-Limburg
-
Ghent, Belgia, 9000
- Rekruttering
- Ghent University Hospital
-
Leuven, Belgia, 3000
- Rekruttering
- Universitair Ziekenhuis Leuven
-
Liège, Belgia, 4000
- Rekruttering
- CHU de Liege
-
Roeselare, Belgia, 8800
- Rekruttering
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5R 1W2
- Rekruttering
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2K5
- Rekruttering
- GIRI Gastrointestinal Research Institute
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N1Y2
- Rekruttering
- Charlton Digestive Disease Centre
-
London, Ontario, Canada, N6K 1M6
- Rekruttering
- London Digestive Disease Institute
-
Oshawa, Ontario, Canada, L1J 0C7
- Rekruttering
- Taunton Surgical Centre
-
Toronto, Ontario, Canada, M6A 3B4
- Rekruttering
- Toronto Immune and Digestive Health Institute Inc
-
-
Quebec
-
Montreal, Quebec, Canada, H3H1E3
- Rekruttering
- Clinique IMD
-
Montreal, Quebec, Canada, H2X 0C1
- Rekruttering
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Aarhus C, Danmark, 8200
- Rekruttering
- Aarhus University Hospital
-
Esbjerg, Danmark, 6700
- Rekruttering
- Sydvestjysk Sygehus
-
Gistrup, Danmark, 9260
- Rekruttering
- NAU New Aalborg University Hospital
-
Herlev, Danmark, 2730
- Rekruttering
- Herlev Hospital
-
Hilleroed, Danmark, 3400
- Rekruttering
- Nordsjaellands Hospital, Hillerod
-
Hvidovre, Danmark, 2650
- Rekruttering
- Hvidovre Hospital
-
København NV, Danmark, 2400
- Rekruttering
- Bispebjerg Hospital
-
Odense C, Danmark, 5000
- Rekruttering
- Odense UH og Svendberg sygehus
-
-
-
-
Alabama
-
Dothan, Alabama, Forente stater, 36305
- Rekruttering
- Digestive Health Specialists of the Southeast
-
Mobile, Alabama, Forente stater, 36608
- Rekruttering
- East View Medical Research
-
-
California
-
Anaheim, California, Forente stater, 92805
- Rekruttering
- Clinnova Research
-
Lancaster, California, Forente stater, 93534
- Rekruttering
- Gastro Care Institute
-
Los Alamitos, California, Forente stater, 90720
- Rekruttering
- United Gastroenterologists
-
Los Angeles, California, Forente stater, 90048
- Rekruttering
- TLC Clinical Research Inc
-
Los Angeles, California, Forente stater, 90067
- Rekruttering
- GastroIntestinal Bioscience
-
San Diego, California, Forente stater, 92123
- Rekruttering
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, Forente stater, 80907
- Rekruttering
- Peak Gastroenterology Associates
-
-
Connecticut
-
Hamden, Connecticut, Forente stater, 06518
- Rekruttering
- Medical Research Center of Connecticut
-
-
Florida
-
Jacksonville, Florida, Forente stater, 32258
- Rekruttering
- Green Leaf Clinical Trials
-
Miami, Florida, Forente stater, 33157-6575
- Rekruttering
- Sanchez Clinical Research, Inc
-
Miami, Florida, Forente stater, 33186
- Rekruttering
- Biodax Medical Research Trials
-
Naples, Florida, Forente stater, 34102
- Rekruttering
- GI Pros Research
-
Orlando, Florida, Forente stater, 32806
- Rekruttering
- Orlando Health Digestive Health Institute
-
Tampa, Florida, Forente stater, 33609
- Rekruttering
- GCP Clinical Research
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30310
- Rekruttering
- Morehouse School of Medicine
-
Atlanta, Georgia, Forente stater, 30342
- Suspendert
- Atlanta Gastroenterology Associates
-
Macon, Georgia, Forente stater, 31201
- Rekruttering
- Gastroenterology Associates of Central GA
-
-
Illinois
-
Northbrook, Illinois, Forente stater, 60062
- Rekruttering
- Comprehensive Gastrointestinal Health Libertyville
-
-
Iowa
-
Clive, Iowa, Forente stater, 50325
- Rekruttering
- Heartland Medical Research Inc
-
-
Kansas
-
Topeka, Kansas, Forente stater, 66606
- Rekruttering
- Cotton-O'Neil Clinical Research Center
-
-
Louisiana
-
Lafayette, Louisiana, Forente stater, 70503
- Rekruttering
- Gastroenterology Clinic of Acadiana
-
Shreveport, Louisiana, Forente stater, 71103
- Rekruttering
- Louisiana State University Health Sciences Center Shreveport
-
-
Maryland
-
Glen Burnie, Maryland, Forente stater, 21061
- Rekruttering
- Woodholme Gastroenterology Associates
-
-
Massachusetts
-
New Bedford, Massachusetts, Forente stater, 02740
- Rekruttering
- Lucida Clinical Trials
-
-
Michigan
-
Farmington Hills, Michigan, Forente stater, 48334
- Rekruttering
- Michigan Center of Medical Research
-
-
New York
-
Carmel, New York, Forente stater, 10512
- Rekruttering
- Westchester Putnam Gastroenterology
-
New York, New York, Forente stater, 10028
- Rekruttering
- New York Gastroenterology Associates
-
New York, New York, Forente stater, 10075
- Suspendert
- Lenox Hill Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, Forente stater, 27599 7080
- Rekruttering
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Forente stater, 28207
- Rekruttering
- Charlotte Gastroenterology and Hepatology, PLLC
-
-
Ohio
-
Mentor, Ohio, Forente stater, 44060
- Rekruttering
- Great Lakes Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73114
- Rekruttering
- Digestive Disease Specialists Inc
-
-
Pennsylvania
-
Uniontown, Pennsylvania, Forente stater, 15401
- Rekruttering
- Frontier Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, Forente stater, 29486
- Rekruttering
- Palmetto Primary and Specialty Care Physicians, Charleston
-
-
Texas
-
Carrollton, Texas, Forente stater, 75010
- Rekruttering
- DFW Clinical Trials
-
Lubbock, Texas, Forente stater, 79424
- Rekruttering
- Lubbock Gastroenterology
-
San Antonio, Texas, Forente stater, 78229
- Rekruttering
- Gastroenterology Research of America, LLC
-
San Antonio, Texas, Forente stater, 78229
- Rekruttering
- Southern Star Research Institute, LLC
-
Tyler, Texas, Forente stater, 75708
- Rekruttering
- The University of Texas Health Science Center at Tyler
-
-
-
-
-
Amiens, Frankrike, 80000
- Rekruttering
- CHU Amiens Picardie
-
Clermont-Ferrand, Frankrike, 63000
- Rekruttering
- Clermont Ferrand University Hospital
-
Marseille, Frankrike, 13015
- Rekruttering
- Aphm - Hopital Nord
-
Nantes, Frankrike, 44000
- Rekruttering
- CHU Nantes - Hotel Dieu
-
Neuilly-sur-Seine, Frankrike, 92200
- Rekruttering
- Clinique Ambroise Pare
-
Nîmes, Frankrike, 30900
- Rekruttering
- CHU Nimes
-
Paris, Frankrike, 75018
- Rekruttering
- APHP - Hopital Bichat - Claude Bernard
-
Paris, Frankrike, 75012
- Rekruttering
- Aphp Hopital Saint Antoine
-
Pierre-Bénite, Frankrike, 69495
- Rekruttering
- Hospices Civils de Lyon CHU Lyon Sud
-
Reims, Frankrike, 51100
- Rekruttering
- CHU de Reims
-
Vandœuvre-lès-Nancy, Frankrike, 54511
- Rekruttering
- Centre Hospitalier Universitaire de Nancy - Hôpital Central
-
Échirolles, Frankrike, 38130
- Rekruttering
- Institut Prive MICI Clinique des Cedres
-
-
-
-
-
Bologna, Italia, 40138
- Rekruttering
- A O U Sant Orsola Malpighi
-
Bolzano, Italia, 39100
- Rekruttering
- Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano
-
Genova, Italia, 16132
- Rekruttering
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Italia, 20132
- Rekruttering
- IRCCS Ospedale San Raffaele
-
Roma, Italia, 00168
- Rekruttering
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Rozzano, Italia, 20089
- Rekruttering
- Istituto Clinico Humanitas
-
Torino, Italia, 10128
- Rekruttering
- Ospedale Mauriziano Torino
-
-
-
-
-
Changzhou, Kina, 213018
- Rekruttering
- Changzhou No 2 Peoples Hospital
-
Chongqing, Kina, 400014
- Rekruttering
- Chongqing General Hospital
-
Fuzhou, Kina, 350005
- Rekruttering
- The First Affiliated Hospital of Fujian Medical University
-
Guangzhou, Kina, 510655
- Rekruttering
- The Sixth Affiliated Hospital Sun Yat sen University
-
Guangzhou, Kina, 510261
- Rekruttering
- The Second Affiliated Hospital of Guangzhou Medical University
-
Nanjing, Kina, 210009
- Rekruttering
- Zhongda Hospital Southeast University
-
Wuhan, Kina, 430060
- Rekruttering
- Renmin Hospital of Wuhan University
-
-
-
-
-
Maastricht, Nederland, 6229 HX
- Rekruttering
- Maastricht UMC
-
Nijmegen, Nederland, 6525 GA
- Rekruttering
- Radboud Umcn
-
Tilburg, Nederland, 5022 GC
- Rekruttering
- St. Elisabeth Ziekenhuis
-
-
-
-
-
Bydgoszcz, Polen, 85 229
- Rekruttering
- Centrum Medyczne Medis ManerMed Sp Z O O
-
Krakow, Polen, 30363
- Rekruttering
- Centrum Medyczne Plejady
-
Krakow, Polen, 31-513
- Rekruttering
- Centrum Medyczne Promed
-
Rzeszów, Polen, 35-326
- Rekruttering
- Centrum Medyczne 'Medyk' Sp. z o.o. K.
-
Szczecin, Polen, 71-434
- Rekruttering
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Polen, 87 100
- Rekruttering
- GASTROMED Kopon Zmudzinski i wspolnicy SP j Specjalistyczne Centrum Gastrologii i Endoskopii
-
Warsaw, Polen, 02-781
- Rekruttering
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Warsaw, Polen, 04 501
- Rekruttering
- Medical Network Sp z o o
-
-
-
-
-
Banská Bystrica, Slovakia, 975 17
- Rekruttering
- FNsP F. D. Roosevelta Banska Bystrica
-
Bratislava, Slovakia, 811 09
- Rekruttering
- Cliniq s.r.o.
-
Košice, Slovakia, 040 13
- Rekruttering
- ENDOMED s.r.o
-
Nové Zámky, Slovakia, 940 34
- Rekruttering
- Fakultna nemocnica s poliklinikou Nove Zamky
-
Prešov, Slovakia, 080 01
- Rekruttering
- GASTRO I. s.r.o.
-
Prešov, Slovakia, 080 01
- Rekruttering
- Gastro LM s.r.o.
-
Rimavská Sobota, Slovakia, 979 12
- Rekruttering
- Vseobecna nemocnica Rimavska Sobota
-
-
-
-
-
Alicante, Spania, 03010
- Rekruttering
- Hosp. Gral. Univ. Dr. Balmis
-
Barcelona, Spania, 08036
- Rekruttering
- Hosp. Clinic de Barcelona
-
Ferrol, Spania, 15405
- Rekruttering
- Hosp. Arquitecto Marcide
-
Gijón, Spania, 33394
- Rekruttering
- Hosp. de Cabuenes
-
Girona, Spania, 17007
- Rekruttering
- Hosp. Univ. Dr. Josep Trueta
-
Madrid, Spania, 28850
- Rekruttering
- Hosp. Univ. de Torrejon
-
Navarra, Spania, 31008
- Rekruttering
- Hosp. de Navarra
-
Santiago de Compostela, Spania, 15706
- Rekruttering
- Hosp. Clinico Univ. de Santiago
-
Seville, Spania, 41009
- Rekruttering
- Hosp. Virgen Macarena
-
-
-
-
-
Greater London, Storbritannia, E1 2AJ
- Rekruttering
- Barts Health NHS Trust
-
Greater London, Storbritannia, NW10 7NS
- Rekruttering
- London North West University Healthcare NHS Trust
-
Iselworth, Storbritannia, TW7 6AF
- Rekruttering
- West Middlesex University Hospital
-
London, Storbritannia, NW3 2QG
- Rekruttering
- Royal Free Hospital
-
London, Storbritannia, W120HS
- Rekruttering
- Imperial College London
-
London, Storbritannia, NW1 2PG
- Rekruttering
- University College London Hospitals Nhs Foundation Trust
-
London, Storbritannia, SW10 9NH
- Rekruttering
- Chelsea And Westminster Hospital
-
Norwich, Storbritannia, NR4 7UQ
- Rekruttering
- Norfolk and Norwich University Hospital
-
Wolverhampton, Storbritannia, WV10 0QP
- Rekruttering
- New Cross Hospital
-
-
-
-
-
Linköping, Sverige, 58185
- Rekruttering
- Linkoping University Hospital
-
Mölndal, Sverige, 431 30
- Rekruttering
- Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
-
Stockholm, Sverige, 171 76
- Rekruttering
- Karolinska Universitetssjukhuset
-
Stockholm, Sverige, 116 30
- Rekruttering
- Ersta sjukhus
-
Stockholm, Sverige, 118 83
- Rekruttering
- Sodersjukhuset
-
Uppsala, Sverige, 751 85
- Rekruttering
- Akademiska Sjukhuset
-
-
-
-
-
Brno, Tsjekkia, 62500
- Rekruttering
- Fakultni nemocnice Brno
-
Brno, Tsjekkia, 636 00
- Rekruttering
- Vojenska nemocnice Brno
-
Hradec Kralova, Tsjekkia, 500 02
- Rekruttering
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Králové, Tsjekkia, 500 12
- Rekruttering
- Hepato-gastroenterologie HK, s.r.o.
-
Ostrava-Poruba, Tsjekkia, 708 00
- Rekruttering
- Fakultni Nemocnice Ostrava
-
Prague, Tsjekkia, 100 00
- Rekruttering
- Fakultni nemocnice Kralovske Vinohrady
-
Prague, Tsjekkia, 14000
- Rekruttering
- Fakultni Thomayerova nemocnice
-
-
-
-
-
Berlin, Tyskland, 10825
- Rekruttering
- GASTRO-Studien
-
Berlin, Tyskland, 12203
- Rekruttering
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF)
-
Erlangen, Tyskland, 91054
- Rekruttering
- Universitatsklinikum Erlangen
-
Grevenbroich, Tyskland, 41515
- Rekruttering
- Praxiszentrum Fur Gastroenterologie und Endoskopie Grevenbroich
-
Jena, Tyskland, 07747
- Rekruttering
- Universitatsklinikum Jena
-
Kiel, Tyskland, 24105
- Rekruttering
- Universitatsklinikum Schleswig Holstein Kiel
-
Ludwigshafen am Rhein, Tyskland, 67067
- Rekruttering
- St. Marien und St. Annastiftskrankenhaus
-
Mannheim, Tyskland, 68167
- Rekruttering
- Universitaetsklinikum Mannheim
-
München, Tyskland, 81675
- Rekruttering
- Klinikum rechts der Isar der TU Munchen
-
-
-
-
-
Budapest, Ungarn, 1088
- Rekruttering
- Semmelweis Egyetem
-
Budapest, Ungarn, 1036
- Rekruttering
- Obudai Egeszsegugyi Centrum Kft
-
Budapest, Ungarn, H-1136
- Rekruttering
- Pannónia Magánorvosi Centrum Kft
-
Budapest, Ungarn, 1082
- Rekruttering
- Semmelweis Egyetem 1
-
Budapest, Ungarn, 1083
- Rekruttering
- Semmelweis Egyetem 2
-
Budapest, Ungarn, 1139
- Rekruttering
- Endomedix
-
Gyöngyös, Ungarn, 3200
- Rekruttering
- Clinexpert Gyongyos Kft
-
Szeged, Ungarn, 6725
- Rekruttering
- Szegedi Tudomanyegyetem
-
-
-
-
-
Graz, Østerrike, 8036
- Rekruttering
- LKH-Univ. Klinikum Graz
-
Innsbruck, Østerrike, 6020
- Rekruttering
- Medizinische Universitatsklinik Innsbruck
-
Linz, Østerrike, 4021
- Rekruttering
- Kepler Universitatsklinikum GmbH
-
Salzburg, Østerrike, 5020
- Rekruttering
- LKH - Universitätsklinikum der PMU Salzburg
-
Vienna, Østerrike, 1090
- Rekruttering
- Medical University Vienna
-
Vienna, Østerrike, 1020
- Rekruttering
- Krankenhaus der Barmherzigen Brüder
-
Wels, Østerrike, 4600
- Rekruttering
- Klinikum Wels Grieskirchen
-
Wiener Neustadt, Østerrike, 2700
- Rekruttering
- Universitatsklinikum Wiener Neustadt
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion criteria:
-
Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
-
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (>=) 220 but less than or equal to (<=) 450
-
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) >= 4 (for participants with isolated ileal disease) or >= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
- a minimum score of 1 for the component of "size of ulcers" AND
- a minimum score of 1 for the component of "ulcerated surface"
-
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
-
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol
Exclusion criteria
- Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
- Currently has or is suspected to have an abscess
- Has an active fistula during screening or at Week 0 with an anticipated need for surgery
- Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
- Currently has a malignancy or has a history of malignancy within 5 years before screening
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Guselkumab
Participants will receive guselkumab induction dose subcutaneously (SC) at Weeks 0, 4, and 8 followed by guselkumab maintenance dose SC once every 4 weeks (q4w) from Week 12 through Week 52. |
Guselkumab will be administered.
Andre navn:
|
|
Eksperimentell: Risankizumab
Participants will receive risankizumab induction dose intravenously (IV) at Weeks 0, 4, and 8 followed by risankizumab maintenance dose SC once every 8 weeks (q8w) from Week 12 through Week 52. |
Risankizumab will be administered. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants with Deep Remission at Week 52
Tidsramme: At Week 52
|
Deep remission is a composite endpoint defined as achieving both clinical remission and endoscopic remission at the participant level. Clinical remission is defined as Crohn's Disease Activity Index (CDAI) score less than (<) 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic remission is defined as Simple Endoscopic Score for Crohn's Disease (SES-CD) less than or equal to (<=) 4 with at least a 2-point reduction from baseline and no sub score greater than (>) 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite Endpoint of Number of Participants with Clinical Remission and Endoscopic Response at Week 52
Tidsramme: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic response is defined as >50 percent (%) improvement from baseline in the SES CD or SES-CD score <= 2 or a decrease of at least 2 points in participants with a baseline score of 4 and isolated ileal disease. This is a composite endpoint defined to measure achievement of both clinical remission and endoscopic response. |
At Week 52
|
|
Number of Participants with Endoscopic Remission at Week 52
Tidsramme: At Week 52
|
Endoscopic remission is defined as SES-CD <= 4 with at least a 2-point reduction from baseline and no sub score > 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
|
Number of Participants with Clinical Remission at Week 52
Tidsramme: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. |
At Week 52
|
|
Number of Participants with Steroid-Free Clinical Remission at Week 52
Tidsramme: At Week 52
|
Steroid-free clinical remission is defined as clinical remission at Week 52 and not receiving corticosteroids for at least 90 days prior to Week 52. Clinical remission is defined as CDAI score < 150-point. |
At Week 52
|
|
Number of Participants with Abnormalities in Laboratory Parameters
Tidsramme: Up to Week 148
|
Number of participants with abnormalities in laboratory parameters (hematology and chemistry) will be reported. |
Up to Week 148
|
|
Number of Participants With Change From Baseline in Laboratory Abnormalities
Tidsramme: Up to week 148
|
Number of participants with change from baseline in laboratory abnormalities (hematology and chemistry) will be reported. |
Up to week 148
|
|
Number of Participants with Adverse Events (AEs), Serious AEs and AEs Leading to Discontinuation of Study Intervention
Tidsramme: Up to Week 165
|
An AE is any untoward medical occurrence in a participant administered a pharmaceutical (investigational or non investigational) product. An AE does not necessarily have a causal relationship with the treatment. An SAE is any untoward medical occurrence that at any dose results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product and is medically important. |
Up to Week 165
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Studieleder: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- CNTO1959CRD3009
- CNTO1959CRD3009 (Annen identifikator: Janssen Research & Development, LLC)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
The data sharing policy of Johnson & Johnson Innovative Medicine is available at www.innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .